These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 27412704)

  • 1. A Computational Model for Docking of Noncompetitive Neuraminidase Inhibitors and Probing their Binding Interactions with Neuraminidase of Influenza Virus H5N1.
    Chintakrindi AS; Martis EA; Gohil DJ; Kothari ST; Chowdhary AS; Coutinho EC; Kanyalkar MA
    Curr Comput Aided Drug Des; 2016; 12(4):272-281. PubMed ID: 27412704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the cross-resistance of oseltamivir to H1N1 and H5N1 influenza A neuraminidase mutations using multidimensional computational analyses.
    Singh A; Soliman ME
    Drug Des Devel Ther; 2015; 9():4137-54. PubMed ID: 26257512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of N-substituted oseltamivir derivatives as potent and selective inhibitors of H5N1 influenza neuraminidase.
    Xie Y; Xu D; Huang B; Ma X; Qi W; Shi F; Liu X; Zhang Y; Xu W
    J Med Chem; 2014 Oct; 57(20):8445-58. PubMed ID: 25255388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the structure-based design of novel inhibitors of H5N1 influenza A virus neuraminidase (NA).
    Mitrasinovic PM
    Biophys Chem; 2009 Mar; 140(1-3):35-8. PubMed ID: 19117662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computational studies of H5N1 influenza virus resistance to oseltamivir.
    Wang NX; Zheng JJ
    Protein Sci; 2009 Apr; 18(4):707-15. PubMed ID: 19309695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding mechanism of H5N1 influenza virus neuraminidase with ligands and its implication for drug design.
    Gong K; Li L; Wang JF; Cheng F; Wei DQ; Chou KC
    Med Chem; 2009 May; 5(3):242-9. PubMed ID: 19442214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analogue inhibitors by modifying oseltamivir based on the crystal neuraminidase structure for treating drug-resistant H5N1 virus.
    Du QS; Wang SQ; Chou KC
    Biochem Biophys Res Commun; 2007 Oct; 362(2):525-31. PubMed ID: 17707775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding mode analysis of anti-influenza drugs in H1N1 (2009) and H5N1 influenza A virus and designing of potential H1N1 inhibitors.
    Singh KhD; Kirubakaran P; Nagamani S; Karthikeyan M
    Int J Comput Biol Drug Des; 2015; 8(1):1-18. PubMed ID: 25869316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacophore-Based Virtual Screening for Identification of Novel Neuraminidase Inhibitors and Verification of Inhibitory Activity by Molecular Docking.
    Batool S; Mushtaq G; Kamal W; Kamal MA
    Med Chem; 2016; 12(1):63-73. PubMed ID: 26152143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuraminidase inhibitor-resistant recombinant A/Vietnam/1203/04 (H5N1) influenza viruses retain their replication efficiency and pathogenicity in vitro and in vivo.
    Yen HL; Ilyushina NA; Salomon R; Hoffmann E; Webster RG; Govorkova EA
    J Virol; 2007 Nov; 81(22):12418-26. PubMed ID: 17855542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel binding patterns between ganoderic acids and neuraminidase: Insights from docking, molecular dynamics and MM/PBSA studies.
    Yang Z; Wu F; Yuan X; Zhang L; Zhang S
    J Mol Graph Model; 2016 Apr; 65():27-34. PubMed ID: 26905206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic behavior of avian influenza A virus neuraminidase subtype H5N1 in complex with oseltamivir, zanamivir, peramivir, and their phosphonate analogues.
    Udommaneethanakit T; Rungrotmongkol T; Bren U; Frecer V; Stanislav M
    J Chem Inf Model; 2009 Oct; 49(10):2323-32. PubMed ID: 19780597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of neuraminidase inhibitors against dual H274Y/I222R mutant strains.
    Hsu KC; Hung HC; HuangFu WC; Sung TY; Eight Lin T; Fang MY; Chen IJ; Pathak N; Hsu JT; Yang JM
    Sci Rep; 2017 Sep; 7(1):12336. PubMed ID: 28951584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drugs against avian influenza a virus: design of novel sulfonate inhibitors of neuraminidase N1.
    Udommaneethanakit T; Rungrotmongkol T; Frecer V; Seneci P; Miertus S; Bren U
    Curr Pharm Des; 2014; 20(21):3478-87. PubMed ID: 24001233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation-induced loop opening and energetics for binding of tamiflu to influenza N8 neuraminidase.
    Kar P; Knecht V
    J Phys Chem B; 2012 May; 116(21):6137-49. PubMed ID: 22553951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comment on "Another look at the molecular mechanism of the resistance of H5N1 influenza A virus neuraminidase (NA) to oseltamivir (OTV)".
    Rungrotmongkol T; Malaisree M; Udommaneethanakit T; Hannongbua S
    Biophys Chem; 2009 Apr; 141(1):131-2; author reply 133. PubMed ID: 19231807
    [No Abstract]   [Full Text] [Related]  

  • 17. Design and synthesis of constrained bicyclic molecules as candidate inhibitors of influenza A neuraminidase.
    Colombo C; Podlipnik Č; Lo Presti L; Niikura M; Bennet AJ; Bernardi A
    PLoS One; 2018; 13(2):e0193623. PubMed ID: 29489903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel small-molecule inhibitor of the avian influenza H5N1 virus determined through computational screening against the neuraminidase.
    An J; Lee DC; Law AH; Yang CL; Poon LL; Lau AS; Jones SJ
    J Med Chem; 2009 May; 52(9):2667-72. PubMed ID: 19419201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and biological evaluation of novel oseltamivir derivatives as potent neuraminidase inhibitors.
    Wang Z; Cheng LP; Zhang XH; Pang W; Li L; Zhao JL
    Bioorg Med Chem Lett; 2017 Dec; 27(24):5429-5435. PubMed ID: 29141777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of potential inhibitors of H5N1 influenza A virus neuraminidase by ligand-based virtual screening approach.
    Karthick V; Ramanathan K; Shanthi V; Rajasekaran R
    Cell Biochem Biophys; 2013 Jul; 66(3):657-69. PubMed ID: 23306969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.